Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

592
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
592
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

633
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
633
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

511
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
511
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

854
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
854
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

579
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
579
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

593
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
593

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perceptions of Educational Needs Among Patients With Ostomies.

Advances in skin & wound care·2026
Same author

Employment Experiences of People Living with Young-Onset Dementia: Perspectives from Workers, Care Partners, and Employment Specialists in Taiwan.

Journal of occupational rehabilitation·2026
Same author

Implementing the Consistently Assess Signs and Symptoms of Heart Failure Guide Into Clinical Practice.

The Journal of cardiovascular nursing·2026
Same author

The Reliability and Validity of Consistently Assess Signs and Symptoms of Heart Failure (CLASS-HF) Guide.

The Journal of cardiovascular nursing·2026
Same author

Bridging a practice gap in patient education on end-of-life defibrillator management: A quality improvement initiative.

Journal of the American Association of Nurse Practitioners·2026
Same author

Digital health interventions for urinary tract infection prevention and management in people living with dementia and their family caregivers: a scoping review.

The Gerontologist·2025

Related Experiment Video

Updated: Apr 8, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.4K

Implementing a Mediterranean Diet App in Patients With Atrial Fibrillation.

Yan Su1, Marilyn A Prasun2, Linda K Cash3

  • 1Yan Su, PhD, RN, Assistant Professor, UMass Dartmouth College of Nursing and Health Sciences, MA.

The Journal of Cardiovascular Nursing
|April 7, 2026
PubMed
Summary

A Mediterranean diet app showed feasibility for atrial fibrillation (AF) patients, improving quality of life and reducing inflammation. Further research is needed to confirm these preliminary findings in AF management.

Keywords:
Mediterranean dietatrial fibrillationinflammationmobile healthpilot study

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.8K
Patient Directed Recording of a Bipolar Three-Lead Electrocardiogram using a Smartwatch with ECG Function
05:03

Patient Directed Recording of a Bipolar Three-Lead Electrocardiogram using a Smartwatch with ECG Function

Published on: December 11, 2019

9.2K

Related Experiment Videos

Last Updated: Apr 8, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.4K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.8K
Patient Directed Recording of a Bipolar Three-Lead Electrocardiogram using a Smartwatch with ECG Function
05:03

Patient Directed Recording of a Bipolar Three-Lead Electrocardiogram using a Smartwatch with ECG Function

Published on: December 11, 2019

9.2K

Area of Science:

  • Cardiology
  • Nutritional Science
  • Digital Health

Background:

  • Atrial fibrillation (AF) is linked to inflammation, symptoms, and reduced quality of life (QoL).
  • The Mediterranean diet's anti-inflammatory potential is recognized, but its impact on AF patients remains understudied.

Purpose of the Study:

  • To evaluate the feasibility of a Mediterranean diet self-monitoring app (Olitor) in patients with symptomatic AF.
  • To assess the preliminary effects of the app on inflammation, AF symptoms, and QoL.

Main Methods:

  • A 3-month, single-arm, pre-post pilot study involving 12 participants with symptomatic paroxysmal AF.
  • Participants used the Olitor app for weekly diet tracking and received tailored feedback.
  • Key outcomes included retention rates, inflammatory markers, AF symptom burden, QoL, physical activity, diet knowledge, self-efficacy, and BMI.

Main Results:

  • The study achieved 83% retention, indicating good feasibility.
  • Significant reductions were observed in Interleukin-6 and C-reactive protein.
  • Improvements were noted in QoL, BMI, self-efficacy, and diet knowledge, with large effect sizes for family QoL and walking activity.

Conclusions:

  • A Mediterranean diet app is a feasible intervention for patients with atrial fibrillation.
  • Preliminary results suggest potential benefits for inflammation, QoL, and lifestyle factors.
  • Further investigation is warranted to confirm these exploratory findings.